Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

469.67 +10.26 (+2.23%)
Streaming Delayed Price Updated: 12:24 PM EDT, Jul 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vertex Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
3 No-Brainer Stocks to Buy in July
Via The Motley Fool
The Best Stocks to Invest $1,000 In Right Now
Via The Motley Fool
Topics Artificial Intelligence Government
Vertex Pharma’s New Cystic Fibrosis Drug Granted Approval By EU
Vertex announced on Tuesday that eligible patients in Ireland, Denmark, and Germany will have access to Alyftrek shortly after receiving regulatory approval from the relevant authorities. 
Via Stocktwits
$100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today
Via Benzinga
How Do Investors Really Feel About Vertex Pharmaceuticals?
Via Benzinga
What's Driving the Market Sentiment Around Vertex Pharmaceuticals?
Via Benzinga
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
Via Benzinga
3 S&P 500 Stocks with Mounting Challenges
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Artificial Intelligence Stocks
Vertex Pharmaceuticals Unusual Options Activity
Via Benzinga
3 Unpopular Stocks Facing Headwinds
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering
FDA launches review of trials that sent American DNA to China without full consent; NIH investigates impact of Biden-era exemption on federally funded research 
Via Benzinga
Friday's session: gap up and gap down stock in the S&P500 index
Let's have a look at what is happening on the US markets on Friday. Below you can find the S&P500 gap up and gap down stocks in today's session. 
Via Chartmill
2 Growth Stocks to Buy and Hold for 10 Years
Via The Motley Fool
Topics Artificial Intelligence Economy World Trade
A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 10 Analysts
Via Benzinga
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Via The Motley Fool
$1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today
Via Benzinga
1 Nasdaq 100 Stock for Long-Term Investors and 2 to Ignore
The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenges like profitability concerns, rising costs, or... 
Via StockStory
Cathie Wood Just Flagged The Start Of A Biotech Revolution: These 2 Stocks With 10x Potential Are Leading It
Cathie Wood is bullish on biotech companies using gene sequencing, AI, and CRISPR tech to cure previously untreatable diseases. 
Via Benzinga
Topics Artificial Intelligence
3 No-Brainer Healthcare Stocks to Buy in June
Via The Motley Fool
4 Monster Stocks to Buy and Hold for the Next Decade
Via The Motley Fool
Topics Artificial Intelligence World Trade
2 Top Stocks to Buy Right Now
Via The Motley Fool
Topics Economy
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
Via The Motley Fool
Topics Economy Government Law Enforcement
3 Top Growth Stocks to Buy in the Second Half of 2025
Via The Motley Fool
Topics Artificial Intelligence Government World Trade
2 Monster Growth Stocks to Buy and Hold for 10 Years
Via The Motley Fool
Topics Bankruptcy
5 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
Via The Motley Fool
Topics Economy Law Enforcement
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years
Via Benzinga
CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?
Via The Motley Fool
VRTX Q1 Earnings Call: New Product Launches and Pipeline Progress Amid Revenue Miss
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 3% year on year to $2.77 billion. The company’s full-year revenue guidance of... 
Via StockStory
Topics Intellectual Property
Warren Buffett Remains Optimistic About America. Here Are Top American Companies Worth Investing In.
Via The Motley Fool
Topics Economy Government Supply Chain
< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.